{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:49:25Z","timestamp":1781585365437,"version":"3.54.5"},"reference-count":21,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAD"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>In vitro, the molecular docking method has been suggested for estimating\nthe biological affinity of the pharmacophores with physiologically active compounds. It is the latter\nstage in molecular docking, and the docking scores are examined using the AutoDock 4.2 tool\nprogram. The chosen compounds can be evaluated for in vitro activity based on the binding\nscores, and the IC50 values can be computed.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The purpose of this work was to create methyl isatin compounds as potential antidepressants,\ncompute physicochemical characteristics, and carry out docking analysis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The protein data bank of the RCSB (Research Collaboratory for Structural Bioinformatics)\nwas used to download the PDB structures of monoamine oxidase (PDB ID: 2BXR) and indoleamine\n2,3-dioxygenase (PDB ID: 6E35). Based on the literature, methyl isatin derivatives\nwere chosen as the lead chemicals. By determining their IC50 values, the chosen compounds were\ntested for in vitro anti-depressant activity.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The binding scores for the interactions of SDI 1 and SD 2 with indoleamine 2,3 dioxygenase\nwere found to be -10.55 kcal\/mol and -11.08 kcal\/mol, respectively, while the scores for\ntheir interactions with monoamine oxidase were found to be -8.76 kcal\/mol and -9.28 kcal\/mol,\nrespectively, using AutoDock 4.2. The relationship between biological affinity and pharmacophore\nelectrical structure was examined using the docking technique. The chosen compounds were\ntested for their ability to inhibit MAO, and the IC50 values for each were found to be 51.20 and\n56, respectively.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>This investigation has identified many novel and effective MAO-A inhibitors from\nthe family of chemicals known as methyl isatin derivatives. Lead optimization was applied to the\nSDI 1 and SDI 2 derivatives. The superior bioactivity, pharmacokinetic profile, BBB penetration,\npre-ADMET profiles, such as HIA (human intestinal absorption) and MDCK (Madin-Darby canine\nkidney), plasma protein binding, toxicity assessment, and docking outcomes, have been obtained.\nAccording to the study, synthesised isatin 1 and SDI 2 derivatives exhibited a stronger\nMAO inhibitory activity and effective binding energy, which may help prevent stress-induced depression\nand other neurodegenerative disorders caused by a monoamine imbalance.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573409919666230523114134","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T06:21:12Z","timestamp":1685082072000},"page":"431-440","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Docking, Synthesis, and I<i>n vitro<\/i> Anti-depressant Activity of Certain Isatin\nDerivatives"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4660-3603","authenticated-orcid":true,"given":"Thulasingam","family":"Muthukumaran","sequence":"first","affiliation":[{"name":"Department of Pharmacology, College of Pharmaceutical Sciences, Dayananda Sagar University, Bengaluru, Karnataka,\nIndia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asok Kumar","family":"K","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences,\nCoimbatore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"M Saleshier","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, College of Pharmacy, Sri Ramakrishna Institute of Paramedical\nSciences, Coimbatore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","unstructured":"Institute of health metrics and evaluation. Global health data exchange (GHDx).  Available from:  http:\/\/ghdx.healthdata.org\/gbd-res ults-tool?params=gbd-api-2019-permalink\/d780dffbe8a381b25e1416884959e88b (Accessed on: 1 May 2021)."},{"key":"ref=2","year":"2020","unstructured":"Depression. World health organization Available from:  https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression (Accessed on: 11th December 2020).2020"},{"key":"ref=3","first-page":"9268083","volume":"2022","author":"Liao D.","year":"2020","unstructured":"Liao D.; Lev C.; Cao L.; Yao D.; Wu Y.; Long M.; Liu N.; Jiang P.; Curcumin attenuates chronic unpredictable mild stress-induced depressive-like behaviours via restoring changes in oxidative stress and the activation of Nrf2 signaling pathway in rats. Oxid Med Cell Longev  2020,2022,9268083","journal-title":"Oxid Med Cell Longev"},{"key":"ref=4","first-page":"397","author":"James N.D.","year":"2006","unstructured":"James N.D.; Drug therapy for depression and anxiety disorder. Goodman and Gilman\u2019s The Pharmacological Basis of Therapeutics  2006,397-416","journal-title":"Goodman and Gilman\u2019s The Pharmacological Basis of Therapeutics"},{"key":"ref=5","first-page":"144","volume":"6","author":"Deweshri R.","year":"2016","unstructured":"Deweshri R.; Pramod K.; Indole derivatives acting on central nervous system. Pharm Sci Bioscientific Res  2016,6(1),144-156","journal-title":"Pharm Sci Bioscientific Res"},{"key":"ref=6","first-page":"318","volume":"6","author":"Vandana K.","year":"2017","unstructured":"Vandana K.; Akash M.; A review on isatin derivatives with diverse biological activities. World J Pharm Res  2017,6(16),318-332","journal-title":"World J Pharm Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.2174\/138945008786949432","volume":"9","author":"Dias R.","year":"2008","unstructured":"Dias R.; de Azevedo W.; Molecular docking algorithms. Curr Drug Targets  2008,9(12),1040-1047","journal-title":"Curr Drug Targets"},{"key":"ref=8","first-page":"207","author":"Alexander H.","year":"2009","unstructured":"Alexander H.; Rolf H.;  Modern Methods of Drug Discovery  2009,207-230","journal-title":"Modern Methods of Drug Discovery"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"e5542","DOI":"10.1590\/1414-431x20165542","volume":"49","author":"No\u00ebl F.","year":"2016","unstructured":"No\u00ebl F.; Nascimento-Viana J.B.; Romeiro L.A.S.; Silva R.O.; Lemes L.F.N.; Oliveira A.S.; Giorno T.B.S.; Fernandes P.D.; Silva C.L.M.; ADME studies and preliminary safety pharmacology of LDT5, a lead compound for the treatment of benign prostatic hyperplasia. Braz J Med Biol Res  2016,49(12),e5542","journal-title":"Braz J Med Biol Res"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1124\/pr.112.007336","volume":"66","author":"Sliwoski G.","year":"2014","unstructured":"Sliwoski G.; Kothiwale S.; Meiler J.; Lowe E.W.; Computational methods in drug discovery. Pharmacol Rev  2014,66(1),334-395","journal-title":"Pharmacol Rev"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"Lipinski C.A.","year":"2004","unstructured":"Lipinski C.A.; Lead- and drug-like compounds: The rule-of-five revolution. Drug Discov Today Technol  2004,1(4),337-341","journal-title":"Drug Discov Today Technol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13065-020-0661-0","volume":"14","author":"Dhiman P.","year":"2020","unstructured":"Dhiman P.; Malik N.; Khatkar A.; Natural based piperine derivatives as potent monoamine oxidase inhibitors: An in silico ADMET analysis and molecular docking studies. BMC Chem  2020,14(1),12","journal-title":"BMC Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ijbiomac.2016.11.062","volume":"95","author":"Kuppusamy A.","year":"2017","unstructured":"Kuppusamy A.; Arumugam M.; George S.; Combining in silico and in vitro approaches to evaluate the acetylcholinesterase inhibitory profile of some commercially available flavonoids in the management of alzheimer\u2019s disease. Int J Biol Macromol  2017,95,199-203","journal-title":"Int J Biol Macromol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.bmc.2010.11.028","volume":"19","author":"Manley-King C.I.","year":"2011","unstructured":"Manley-King C.I.; Bergh J.J.; Petzer J.P.; Inhibition of monoamine oxidase by selected C5- and C6-substituted isatin analogues. Bioorg Med Chem  2011,19(1),261-274","journal-title":"Bioorg Med Chem"},{"key":"ref=15","first-page":"1","volume":"6","author":"Grewal A.S.","year":"2014","unstructured":"Grewal A.S.; Isatin derivatives with several biological activities. Inter J Pharm Res  2014,6(1),1-7","journal-title":"Inter J Pharm Res"},{"key":"ref=16","first-page":"9","volume":"7","author":"Nerella R.","year":"2011","unstructured":"Nerella R.; Lingala S.; Manda S.; Synthesis and CNS activity of new indole derivatives. Int J Pharm Sci Rev Res  2011,7,9-13","journal-title":"Int J Pharm Sci Rev Res"},{"key":"ref=17","first-page":"133","volume":"36","author":"Medvedev A.E.","year":"1995","unstructured":"Medvedev A.E.; Ivanor. Introduction of indole derivatives with MAO-A and MAO-B studies on the structure inhibitory activity relationship. Biochem Int  1995,36,133","journal-title":"Biochem Int"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","volume":"47","author":"Porsolt R.D.","year":"1978","unstructured":"Porsolt R.D.; Anton G.; Blavet N.; Jalfre M.; Behavioural despair in rats: A new model sensitive to antidepressant treatments. Eur J Pharmacol  1978,47(4),379-391","journal-title":"Eur J Pharmacol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40203-017-0034-0","volume":"5","author":"Kandagalla S.","year":"2017","unstructured":"Kandagalla S.; Sharath B.S.; Bharath B.R.; hani U.; Manjunatha H.; Molecular docking analysis of curcumin analogues against kinase domain of ALK5. In Silico Pharmacol  2017,5(1),15","journal-title":"In Silico Pharmacol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12906-018-2116-x","volume":"18","author":"Khan M.F.","year":"2018","unstructured":"Khan M.F.; Nahar N.; Rashid R.B.; Chowdhury A.; Rashid M.A.; Computational investigations of physicochemical, pharmacokinetic, toxicological properties and molecular docking of betulinic acid, A constituent of Corypha taliera (Roxb.) with phospholipase A2 (PLA2). BMC Complement Altern Med  2018,18(1),48","journal-title":"BMC Complement Altern Med"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s42269-018-0002-9","volume":"42","author":"Yasser A.","year":"2018","unstructured":"Yasser A.; Hussein G.; Eman N.; Assessment of the antidepressant effect of caffeine using rat model of depression induced by reserpine. Bull Natl Res Cent  2018,42(36),1-9","journal-title":"Bull Natl Res Cent"}],"container-title":["Current Computer-Aided Drug Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573409919666230523114134","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/217236\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573409919666230523114134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T15:02:56Z","timestamp":1714575776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/217236\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573409919666230523114134","relation":{},"ISSN":["1573-4099"],"issn-type":[{"value":"1573-4099","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-09-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}